Content

01

5-Minute Deep Dive

Background and Objectives

What We Know

Strongest Associations Between NDMA and Cancer

NDMA Intake Patterns and Demographic Risks

02

History

Zantac Timeline 1977–2020

Parties Involved in Zantac’s Development

Zantac’s FDA Testing Process

Post-Marketing Surveillance

The FDA’s Recall of Zantac

03

Zantac's Chemical Composition

Mechanism of Action

Pharmacokinetics (Drug Movement)

The Process of NDMA Development in Zantac

04

The Dangers of NDMA

A Known Carcinogen

Temperature-Specific Dangers

Perspectives From Major Health Organizations

05

Links Between NDMA & Cancer

Early Studies Demonstrating NDMA Cancer Causation

Strength of Association Metrics

06

Areas of Liability

Fraudulent Concealment

Possible Gaps in Testing

Potential Storage Liabilities

07

Assesssing a Plaintiff’s Fit for the Zantac Class

Zantac Intake Criteria

Pre-Existing Conditions that Complicate Eligibility

08

Possible Angles from the Defense

09

Assessing Damages

Factors to Consider

10

Determining the Most Appropriate Expert Witnesses

Proving Liability

Proving Causation

Proving Damages

11

Glossary

12

Works Cited

Areas of interest

Med

Oncology

Personal Injury

Products Liability

Subscribe for unlimited access to every document

A subscription to the Research Guide Library, gets you complete access to all our medico-legal research for a fraction of the cost.